Loading

MRK — Merck & Co., Inc. · PureTicker

Dashboard Screener Smart Money Ask

More▾

Chart read News S&P 500 Pricing Methodology

☰✕

Dashboard Screener Smart Money Ask

Chart read News S&P 500 Pricing Methodology

MRK

Merck & Co., Inc.F2515-min delayed · EOD close

148.36▼ −0.78% downas of 2026-11-02mkt cap $366B

Pharmaceutical Preparations · SIC 2834 · CIK 0000310158

Key Stats Financials Fair Value Quality Technicals Peers Smart Money Ratings News

Chart read News S&P 500 Pricing Methodology Terms Privacy

Research and education only. Not investment advice, not a broker or registered adviser, and no trade execution. Data from SEC EDGAR and Yahoo Finance.

Market cap

$366B

P/E

115.4

Net margin

4.8%

ROE

7.6%

Revenue

$66.6B

latest annual

Net income

$3.2B

latest annual

Shares out

2.5B

Free cash flow

$16.1B

52-week range

Current: 148.36

▲

Low

80.62

High

155.54

Quality score

25/100

F

Growth14

Business quality20

missing: grossMargin, operatingMargin

Financial healthno data

missing: debtToEquity, cashToLiabilities

Valuation40

Computed from filed fundamentals against fixed reference bands. Not a recommendation, and not a peer percentile.